Skip to main content
HairCited

الوخز بالإبر الدقيقة لـ Alopecia Areata (الثعلبة البقعية)

A

بناءً على 32 دراسة (1 meta-analysis, 9 RCTs) بمشاركة 1,908 مشاركًا إجمالاً. 25/32 دراسة تُظهر تأثيرات إيجابية.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

الخلاصة

Microneedling has strong evidence for supporting hair regrowth in alopecia areata, especially when combined with topical medications, and is backed by multiple randomized controlled trials.

  • 25 out of 32 studies show positive effects, with 9 RCTs providing robust evidence
  • Works by creating micro-injuries that stimulate healing responses and improve drug absorption
  • Most effective when combined with topical agents like corticosteroids or vitamin D3
  • Both professional clinical procedures and at-home derma rollers have been studied

Key Study Findings

scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) مقابل: Placebo التأثير: None None
retrospective cohort n=7 Open-label
Combination Therapy With CGF and Microneedling-Assisted Compound Betamethasone for Resistant Alopecia Areata: A Pilot Study.
Dose: Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip مقابل: Placebo التأثير: 85.7% achieved complete recovery; 14.3% achieved >50% regrowth; significant SALT score improvement None
randomized controlled trial n=24 18 weeks Open-label
A Comparative Clinical and Trichoscopic Study Between Fractional Radiofrequency Microneedling Versus Intralesional Steroids in Treatment …
Dose: Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals مقابل: Placebo التأثير: Comparable efficacy between FRM and ILCS; nonsignificant differences in trichoscopic scores, PGA, an None
review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera مقابل: Placebo التأثير: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
animal study 2 weeks
Investigating the potential mechanism of microneedling in alopecia areata mice based on 16S rRNA sequencing …
Dose: Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment مقابل: Placebo التأثير: Microneedling enhanced hair growth; restored gut microbiome diversity; reduced acetic acid and propa None

Key Statistics

34

الدراسات

1908

المشاركون

Positive

A

التقييم

Referenced Papers

Skin appendage disorders 2024 5 اقتباسات
The Journal of … 2024 2 اقتباسات
Dermatology and therapy 2022 43 اقتباسات
Journal of the … 2020 10 اقتباسات
Proceedings (Baylor University. … 2020 8 اقتباسات
Journal of the … 2018 114 اقتباسات
Journal of cutaneous … 2014 80 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

hairloss:
1.5 mm depth, weekly sessions

الحد الأعلى: Not applicable

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip -- Positive 7
None -- Mixed --
Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals 18 weeks Neutral 24
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment 2 weeks Positive --
Microinfusion of medications into the skin (MMP) using tattoo devices; various drugs (minoxidil, ste -- Positive --
Melatonin 3 mg/kg; PBM diode laser 660nm, 100mW, 3 J/point, 2 sessions/week 12 weeks Mixed 60

أفضل وقت للتناول: Weekly sessions; avoid minoxidil for 24 hours post-treatment

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Scalp redness and inflammation (24-72 hours)
  • Mild bleeding at treatment site
  • Scalp tenderness and soreness
  • Rare: infection if proper sterilization not maintained

التفاعلات المعروفة

  • Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
  • Blood thinners (may increase bleeding during procedure)
  • Topical retinoids (discontinue 3-5 days before treatment)

الحد الأقصى المسموح به: Not applicable

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does الوخز بالإبر الدقيقة help with Alopecia Areata (الثعلبة البقعية)?
Based on 34 studies with 1,908 participants, there is strong evidence from multiple clinical trials that الوخز بالإبر الدقيقة may support Alopecia Areata (الثعلبة البقعية) management. Our evidence grade is A (Strong Evidence).
How much الوخز بالإبر الدقيقة should I take for Alopecia Areata (الثعلبة البقعية)?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of الوخز بالإبر الدقيقة?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for الوخز بالإبر الدقيقة and Alopecia Areata (الثعلبة البقعية)?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 34 peer-reviewed studies with 1,908 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.